NewsRoom Articles - Page 100 of 218

MondayOct 24, 2022 10:30 am

Silo Pharma Inc.’s (NASDAQ: SILO) Novel Ketamine Formulation Undergoing Safety Evaluation, Pursuing Regulatory Pathway

Ketamine used for decades in large doses for surgical anesthesia, low-dose treatments currently prescribed for pain relief, sedation, and treatment-resistant depression Silo’s time-released ketamine formulation SP-26 currently undergoing safety evaluation, study to uncover maximum tolerated dosing data for future trials SP-26 previously reported positive results in reducing neuropathic nerve pain Silo preparing FDA Pre-Investigational New Drug (“IND”) package for SP-26, intends to pursue 505(b)(2) regulatory pathway Ketamine was approved in the United States in 1970 and has been used extensively for surgical anesthesia. Since then, use of the drug in small doses has expanded considerably to treat pain and treatment-resistant…

FridayOct 21, 2022 1:53 pm

Study Finds Livers with a Cumulative Age of 100 Years

Scientists from University of Texas Southwestern Medical Center, Dallas, and Andover, Massachusetts and TransMedics have discovered that there are transplanted livers that have a cumulative age exceeding one hundred years. The team of scientists studied those livers in order to find out why they were so resilient. They presented their discoveries at the 2022 Scientific Forum of the American College of Surgeons Clinical Congress. For their research, the scientists used the UNOS STAR file to locate livers that had a cumulative age equal to or exceeding one hundred years. They discovered that of the total number of livers transplanted in…

ThursdayOct 20, 2022 2:35 pm

Patient Plays Sax During Lengthy Surgery to Remove Brain Tumor

Last week, a musician had his brain tumor removed while fully conscious during a nine-hour surgery that took place in Italy. During the operation, which was carried out at the Paideia International Hospital in Rome, the 35-year old musician played his saxophone. This helped the surgeon map out different functions of the brain as he operated. Dr. Christian Brogna, the neurosurgeon who performed the operation, stated in an interview that there were no negative effects observed in the patient after the tumor was successfully removed. Brogna led a team of highly qualified specialists during the operation, which used state-of-the-art technology.…

WednesdayOct 19, 2022 11:08 am

New Research Finds Gaming Can Cause Fatal Arrhythmias

A new case-series study has discovered that gaming can trigger deadly heart arrhythmias in children. Heart arrhythmias are irregular heartbeats that occur when the electrical signals coordinating the beating of an individual’s heart aren’t working properly. The researchers stated that children who fainted while they played video games needed to be evaluated. They also urged physicians to be aware of this possible risk in children with arrhythmia syndromes while gaming. Dr. Christian Turner, one of the leads of the study, stated that the population at risk was unusually small and if there was no suspicious family history, then no cardiac…

TuesdayOct 18, 2022 2:23 pm

Cancer Studies Provide Researchers with New Information on Ovarian Cancer Development, Growth

Two studies recently conducted by Cedars-Sinai Cancer scientists have discovered new information that may improve the understanding of why some patients don’t respond to treatment and what drives ovarian cancer development. Epithelial ovarian cancer is the most common ovarian cancer type, developing in the epithelial tissue. It is estimated that roughly 85% of ovarian tumors are epithelial. The first study affords researchers a better understanding into how ovarian tumors develop resistance to treatment. Resistance usually develops in nearly 80% of high-grade serous tumors of patients with ovarian cancer. The co-first author for this study, Michelle Jones, stated that whole genome…

TuesdayOct 18, 2022 9:45 am

Odyssey Health, Inc. (ODYY) Updates Progress of its Concussion Drug Development Program; Communicating with the FDA for permission to start phase II clinical trial of its PRV-002 Drug Candidate

Odyssey acquired IP and all rights to PRV-002, its lead drug candidate for the treatment of concussions, on March 1, 2021, and has since made notable progress in a strategic move to have the drug approved by the FDA Since the acquisition, the company has completed IND enabling studies and all cohorts for Phase I SAD and MAD clinical trials for its lead drug candidate In pre-clinical studies PRV-002 has demonstrated equivalent, if not superior neuroprotective effects compared to related neurosteroids, offering proof of reduced behavioral pathology associated with brain injury symptoms, easily crossing the blood-brain barrier to rapidly eliminate…

MondayOct 17, 2022 11:04 am

Researchers Develop AI Tool That Scans Retina, Detects Heart Disease in One Minute

Heart disease, which is estimated to take around 17.9 million lives annually, is among the leading causes of death across the world. This condition commonly affects people aged 20 and older across the united States, with one American suffering a heart attack every 40 seconds. In total, roughly 800,000 individuals suffer heart attacks every year. Although heart diseases such as coronary artery disease cannot be cured, early detection can allow for the management of symptoms to reduce a patient’s chances of having a heart attack. Researchers have now developed software that could allow physicians to detect heart disease in only…

FridayOct 14, 2022 12:59 pm

Allergies: How They Occur and Why They Sometimes Disappear

Allergies occur when an individual’s immune system reacts to any substance, including dust, pollen or animal fur, flagging the substance as dangerous and attacking it as a protective measure. When the body attacks the substance, referred to as an allergen, it prompts the immune system to release IgE antibodies. This in turn prompts the release of histamine, which causes an allergic reaction that results in swelling, redness and itching. In extreme cases, allergic reactions can lead to death. Pet allergies in particular are common especially in young children, with fur being enough to cause an allergic reaction. Common symptoms include…

FridayOct 14, 2022 10:30 am

Odyssey Health, Inc. (ODYY) Seeking to Provide Solution to Concussion-Prone Military and NFL with Development of PRV-002 Drug Candidate

Odyssey Health is a medical company developing unique, life-saving products that address unmet clinical needs such as concussion, which does not have an FDA-approved therapeutic The company has developed PRV-002, a neurosteroid for the treatment of concussion, and an intranasal delivery device that delivers the drug into the upper chamber of the nasal cavity for onward travel into the brain Odyssey’s just concluded Phase I clinical trial shows that PRV-002 is safe and well tolerated The findings from the study are likely to benefit the military as well as the NFL, given military personnel and players frequently suffer concussions In…

ThursdayOct 13, 2022 11:49 am

Researchers Uncover Vital Clues on Drivers Behind Growth, Size of Brain Tumors

A new study has discovered a crucial new piece of information for the treatment and prevention of brain tumors. The study was led by Mount Sinai Hospital’s Lunenfeld-Tannenbaum Research Institute, in collaboration with the Mayo Clinic Center for Individualized Medicine and the Mayo Clinic Comprehensive Cancer Center. Its findings were reported in the Science journal. Gliomas are a type of tumor that occur in the brain and spinal cord. These tumors usually start to develop in the glial cells, which help nerve cells function. The average length of survival for patients with these tumors is estimated at eight months with…